This protocol addresses posterior reversible encephalopathy syndrome (PRES) occurring in the setting of eclampsia during or after pregnancy. Diagnosis is based on typical clinical manifestations in combination with neuroimaging characteristics, interpreted within the obstetric context.
Management in this scenario involves an intravenous agent as the treatment of choice, directed at both hypertension and seizure control. Treatment selection is guided by careful consideration of maternal and fetal health throughout.
DOI: 10.1056/NEJMra2114482
The diagnosis of PRES with eclampsia during or after pregnancy is based on typical clinical manifestations and neuroimaging characteristics.
In consideration of fetal and maternal health, the treatment of choice for hypertension and seizures has generally been intravenous magnesium sulfate.
View source ↗